← Open Payments lookup

FADI AL-KHAYER: Open Payments

NPI 1861477069 · STORRS, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$89,914 in 133 payments from 11 companies in 2025. Trend: 2023 $98,787 · 2024 $88,647 · 2025 $89,914

Speaker / faculty: $73,921Honoraria: $7,220Travel & lodging: $5,756Food & beverage: $3,013Education: $4
CompanyPaymentsAmount
Lilly USA, LLC80$46,800
Corcept Therapeutics30$25,000
Novo Nordisk Inc14$17,845
Xeris Pharmaceuticals, Inc.1$100
Amgen Inc.2$40
Insulet Corporation1$27
Almatica Pharma LLC1$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21
Intra-Sana Laboratories1$21
RECORDATI_RARE_DISEASES_INC.1$17

Products named: Korlym, Ozempic, MOUNJARO, RECORLEV, ZEPBOUND, Omnipod, TERIPARATIDE, TEPEZZA.

Industry payments across CT — which companies pay providers there.